StonvexLoading…
StonvexStonvexStonvexCore line items from BBT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $29.95M | $16.54M | $16.23M | $40.87M |
Operating Income | $121.86M | $91.69M | $93.91M | $113.82M |
Net Income | $90.27M | $68.72M | $75.00M | $92.53M |
EPS (Diluted) | $1.03 | $0.77 | $0.85 | $2.02 |
Total Assets | $23.22B | $11.91B | $12.43B | $11.66B |
Total Liabilities | $20.72B | $10.68B | $11.42B | $10.71B |
Cash & Equivalents | $2.04B | $543.67M | $133.03M | $382.96M |
Free Cash Flow OCF − CapEx | $212.16M | $99.97M | $104.24M | $109.24M |
Shares Outstanding | 87.70M | 46.42M | 43.50M | 44.36M |